BSX
Price
$88.95
Change
+$0.29 (+0.33%)
Updated
Dec 20 closing price
38 days until earnings call
NTRA
Price
$161.88
Change
+$3.79 (+2.40%)
Updated
Dec 20 closing price
66 days until earnings call
Ad is loading...

BSX vs NTRA

Header iconBSX vs NTRA Comparison
Open Charts BSX vs NTRABanner chart's image
Boston Scientific
Price$88.95
Change+$0.29 (+0.33%)
Volume$15.91M
CapitalizationN/A
Natera
Price$161.88
Change+$3.79 (+2.40%)
Volume$3.14M
CapitalizationN/A
BSX vs NTRA Comparison Chart
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. NTRA commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and NTRA is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BSX: $88.95 vs. NTRA: $161.88)
Brand notoriety: BSX: Notable vs. NTRA: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 260% vs. NTRA: 239%
Market capitalization -- BSX: $100.1B vs. NTRA: $11.04B
BSX [@Medical Specialties] is valued at $100.1B. NTRA’s [@Medical Specialties] market capitalization is $11.04B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileNTRA’s FA Score has 1 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • NTRA’s FA Score: 1 green, 4 red.
According to our system of comparison, BSX is a better buy in the long-term than NTRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while NTRA’s TA Score has 4 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 4 bearish.
  • NTRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BSX is a better buy in the short-term than NTRA.

Price Growth

BSX (@Medical Specialties) experienced а -1.29% price change this week, while NTRA (@Medical Specialties) price change was -2.80% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +1.84%, and the average quarterly price growth was +2.97%.

Reported Earning Dates

BSX is expected to report earnings on Jan 29, 2025.

NTRA is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than NTRA($11B). NTRA YTD gains are higher at: 158.429 vs. BSX (53.866). BSX has higher annual earnings (EBITDA): 3.45B vs. NTRA (-397.8M). NTRA (879M) and BSX (865M) have equal amount of cash in the bank . NTRA has less debt than BSX: NTRA (442M) vs BSX (9.49B). BSX has higher revenues than NTRA: BSX (14.2B) vs NTRA (1.08B).
BSXNTRABSX / NTRA
Capitalization100B11B909%
EBITDA3.45B-397.8M-866%
Gain YTD53.866158.42934%
P/E Ratio63.64N/A-
Revenue14.2B1.08B1,311%
Total Cash865M879M98%
Total Debt9.49B442M2,148%
FUNDAMENTALS RATINGS
BSX vs NTRA: Fundamental Ratings
BSX
NTRA
OUTLOOK RATING
1..100
8188
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
1024
SMR RATING
1..100
7498
PRICE GROWTH RATING
1..100
4337
P/E GROWTH RATING
1..100
30100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (58) in the Biotechnology industry is in the same range as BSX (80) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (10) in the Medical Specialties industry is in the same range as NTRA (24) in the Biotechnology industry. This means that BSX’s stock grew similarly to NTRA’s over the last 12 months.

BSX's SMR Rating (74) in the Medical Specialties industry is in the same range as NTRA (98) in the Biotechnology industry. This means that BSX’s stock grew similarly to NTRA’s over the last 12 months.

NTRA's Price Growth Rating (37) in the Biotechnology industry is in the same range as BSX (43) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to BSX’s over the last 12 months.

BSX's P/E Growth Rating (30) in the Medical Specialties industry is significantly better than the same rating for NTRA (100) in the Biotechnology industry. This means that BSX’s stock grew significantly faster than NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXNTRA
RSI
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
48%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME29.820.82
+2.83%
GameStop Corp
AAPL254.494.70
+1.88%
Apple
SPY591.157.02
+1.20%
SPDR® S&P 500® ETF Trust
BTC.X97224.730000-531.203100
-0.54%
Bitcoin cryptocurrency
TSLA421.06-15.11
-3.46%
Tesla

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with ISRG. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.33%
ISRG - BSX
52%
Loosely correlated
+0.10%
ZBH - BSX
47%
Loosely correlated
+1.24%
EW - BSX
44%
Loosely correlated
+1.19%
MDT - BSX
41%
Loosely correlated
+1.30%
ABT - BSX
40%
Loosely correlated
+1.61%
More

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with VCYT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+2.40%
VCYT - NTRA
38%
Loosely correlated
+4.66%
RDNT - NTRA
38%
Loosely correlated
+1.85%
CDNA - NTRA
36%
Loosely correlated
+0.29%
BSX - NTRA
36%
Loosely correlated
+0.33%
IRIX - NTRA
36%
Loosely correlated
-4.09%
More